호흡 모니터링 기기 시장 규모는 2024년부터 2030년까지 예측 기간 동안 5.73%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다. 호흡 모니터링 기기 시장은 2024년부터 2030년까지 예측 기간 동안 호흡기 질환의 유병률 증가, 호흡기 질환과 관련된 위험 요소 증가, 호흡기 질환에 취약한 노인 인구 증가로 인해 상당한 성장을 보일 것으로 예상됩니다.
세계보건기구(WHO)의 2024년 자료에 따르면 2019년 전 세계적으로 약 2억 6,200만 명이 천식을 앓고 있는 것으로 추정됩니다. 또한 WHO의 2022년 암 관련 데이터에 따르면 2020년 전 세계적으로 약 221만 명의 폐암 환자가 기록됐습니다.
폐에 영향을 미치는 급성 호흡기 감염의 일종인 폐렴 사례 증가는 호흡 모니터링 기기 시장의 성장에 영향을 미치는 또 다른 요인으로, WHO의 2021년 발표에 따르면 전 세계 폐렴은 5세 미만 어린이 사망의 14%를 차지하며 2019년 74만180명의 어린이가 사망했습니다. 어린이가 사망했습니다.
또한 결핵, 폐부종, 기흉 또는 기흉, 석면증과 같은 다른 호흡기 질환의 전 세계적인 발생은 호흡 모니터링 기기에 대한 수요를 더욱 촉진하고 호흡 모니터링 기기 시장에 긍정적인 영향을 미칩니다.
이 보고서는 세계 호흡 모니터링 기기 시장에 대해 조사했으며, 시장 개요와 함께 웨어러블 기기별/제품 유형별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
Respiratory Monitoring Devices Market by Wearability (Wearable and Non-Wearable), Product Type (Spirometers, Pulse Oximeters, Capnographs, Sleep Tech Devices, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of respiratory disorders and its risk factors, the rising geriatric population prone to respiratory ailments, among others across the globe.
The Respiratory Monitoring Devices market is estimated to grow at a CAGR of 5.73% during the forecast period from 2024 to 2030. The Respiratory Monitoring Devices market is poised for substantial growth owing to the increasing prevalence of respiratory disorders, increasing risk factors associated with respiratory disorders, and the rising geriatric population prone to respiratory ailments, among others during the forecast period from 2024 to 2030.
Respiratory Monitoring Devices Market Dynamics:
According to the World Health Organization (WHO) 2024, it was estimated that worldwide around 262 million people were suffering from asthma in 2019. Also, as per the WHO data on cancer 2022, globally around 2.21 million cases of lung cancer were recorded in 2020.
The rising cases of pneumonia, which is a type of acute respiratory infection affecting the lungs is another factor impacting the growth of the respiratory monitoring devices market. As per the WHO 2021, worldwide pneumonia caused 14% of all deaths of children under 5 years old, killing 740,180 children in 2019.
Moreover, the occurrences of other respiratory disorders such as tuberculosis, pulmonary edema, pneumothorax or atelectasis, asbestosis, and others worldwide will further drive the demand for respiratory monitoring devices, positively impacting the respiratory monitoring devices market.
As per the WHO 2021, worldwide around 10 million people were suffering from tuberculosis (TB) with 5.6 million cases in men, 3.3 million cases in women, and 1.1 million cases in children in 2020. This indicated the growing need for monitoring devices so that timely treatment for TB can be provided.
Thus, the interplay of all the above-mentioned factors is expected to boost the market demand for respiratory monitoring devices, and therefore its overall market during the forecast period from 2024 to 2030.
However, the high cost associated with respiratory monitoring devices, and the stringent regulatory approvals for the devices, among others may act as restraining factors for the overall growth of the Respiratory Monitoring Devices during the forecast period.
Respiratory Monitoring Devices Market Segment Analysis:
Respiratory Monitoring Devices Market by Wearability (Wearable and Non-Wearable), Product Type (Spirometers, Pulse Oximeters, Capnographs, Sleep Tech Devices, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the Respiratory Monitoring Devices market, the spirometers category is projected to hold a considerable market share in 2023. This can be attributed to the various features and applications provided by spirometers, along with the product development activities in the spirometers category, during the forecast period.
Spirometers form a valuable tool for studying multiple respiratory problems such as asthma, chronic obstructive pulmonary disease (COPD), and others. They are also used to evaluate possible respiratory disorders and can be used to test lung functioning before surgery.
Spirometers take into account the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled. The commonly taken measurements by spirometers include Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), and FEV1/FVC.
In March 2021, Vyaire Medical announced the launch of the AioCare mobile spirometry system in more than 15 countries across Europe, the Middle East, and Australia. This clinically proven technology expanded upon Vyaire's deep respiratory diagnostics expertise allowing physicians to promptly diagnose pulmonary diseases including asthma and COPD as accurately as hospital-grade spirometers. It also performs high-quality patient monitoring via advanced digital connectivity at home.
Hence, owing to all the aforementioned factors, the market will experience an increased demand for spirometers, thus driving the respiratory monitoring devices market during the forecast period.
North America is expected to dominate the overall Respiratory Monitoring Devices market:
North America is expected to account for the highest proportion of the Respiratory Monitoring Devices market in 2023, out of all regions. North America is also expected to dominate the overall Respiratory Monitoring Devices market during the given forecast period from 2024 to 2030.
The major factors driving the market for Respiratory Monitoring Devices in North America are the presence of a large patient pool suffering from respiratory disorders, product approvals, and the presence of a sophisticated healthcare infrastructure in the US, among others across the region during the forecast period.
According to data provided by the Centers for Disease Control and Prevention 2023, it was recorded that 24,963,874 people in the United States were suffering from asthma in the year 2021. The source further stated that 4,675,475 children below the age of 18 years, had reported having asthma in 2021, in the United States. In another set of statistics published by the Centers for Disease Control and Prevention 2023, it was stated that around 14.2 million adults were diagnosed with chronic obstructive pulmonary disorder in the year 2021.
The high patient population base associated with respiratory disorders is expected to propel the demand for respiratory monitoring devices in the US, in the upcoming years.
In 2020, Aluna, a portable spirometry device received clearance from the US Food and Drug Administration, which monitors lung health at home without the need to visit the doctor.
Thus, due to the interplay of all the above-mentioned factors, the market growth for respiratory monitoring devices is expected to surge in the United States during the forecast period from 2024 to 2030.
Respiratory Monitoring Devices Market Key Players:
Some of the key market players operating in the Respiratory Monitoring Devices market include Koninklijke Philips NV, ResMed, Medtronic plc., GE Healthcare, Draegerwerk, Seimens Healthineers, Nihon Kohden Corporation, Vyaire Medical, Inc., Hamilton Medical, Getinge Inc., BD, Airsep Corporation, Smiths Medical, Masimo, Fisher and Paykel Healthcare, and others.
Recent Developmental Activities in the Respiratory Monitoring Devices Market:
Key Takeaways from the Respiratory Monitoring Devices Market Report Study:
Target audience who can be benefited from this Respiratory Monitoring Devices Market Report Study:
Frequently Asked Questions for the Respiratory Monitoring Devices Market:
A respiratory monitor is a device that can be used in a hospital or in the home to monitor respiration rate. These devices measure respiratory rate and heart rate, transmitting real-time data displaying and log values for various time points.
The Respiratory Monitoring Devices market is estimated to grow at a CAGR of 5.73% during the forecast period from 2024 to 2030.
The Respiratory Monitoring Devices market is poised for substantial growth, owing to the increasing prevalence of respiratory disorders, increasing risk factors associated with respiratory disorders, and the rising geriatric population prone to respiratory ailments, among others during the forecast period from 2024 to 2030.
Some of the key market players operating in the Respiratory Monitoring Devices market include Koninklijke Philips NV, ResMed, Medtronic plc., GE Healthcare, Draegerwerk, Seimens Healthineers, Nihon Kohden Corporation, Vyaire Medical, Inc., Hamilton Medical, Getinge Inc., BD, Airsep Corporation, Smiths Medical, Masimo, Fisher and Paykel Healthcare, and others.
North America is expected to account for the highest proportion of the Respiratory Monitoring Devices market in 2023, out of all regions. The major factors driving the market for Respiratory Monitoring Devices in North America are the presence of a large patient pool suffering from respiratory disorders, product approvals, and the presence of a sophisticated healthcare infrastructure in North America, among others across the region during the forecast period.